TGTX - TG THERAPEUTICS, INC.
29.03
-0.160 -0.551%
Share volume: 2,002,927
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$29.19
-0.16
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-09-2024 | 11-07-2024 | 03-03-2025 | 05-09-2025 | 08-08-2025 | 11-05-2025 | |
| Total revenue | 63.474 M | 73.466 M | 83.879 M | 108.185 M | 120.856 M | 141.148 M | 161.709 M | |
| Cost of revenue | 5.441 M | 8.304 M | 0.000 | 24.741 M | 15.541 M | 18.938 M | 28.093 M | |
| Gross profit | 58.033 M | 65.162 M | 83.879 M | 83.444 M | 105.315 M | 122.210 M | 133.616 M | |
| 12.28% | 28.72% | -0.52% | 26.21% | 16.04% | 9.33% | |||
| Operating expenses | 57.964 M | 56.346 M | 62.104 M | 62.836 M | 96.693 M | 87.367 M | 104.251 M | |
| Selling general and admin | 27.694 M | 38.790 M | 41.966 M | 38.961 M | 50.331 M | 55.585 M | 63.373 M | |
| Research and development | 30.270 M | 17.556 M | 20.138 M | 23.875 M | 46.362 M | 31.782 M | 40.878 M | |
| Total expenses | 72.744 M | 56.346 M | 71.445 M | 53.495 M | 96.693 M | 87.367 M | 104.251 M | |
| -22.54% | 26.80% | -25.12% | 80.75% | -9.64% | 19.33% | |||
| Operating income | -9.270 M | 8.816 M | 12.434 M | 29.949 M | 8.622 M | 34.843 M | 29.365 M | |
| Ebit | -9.270 M | 10.528 M | 15.100 M | 32.384 M | 12.225 M | 37.636 M | 32.630 M | |
| Pretax income | -10.678 M | 6.551 M | 4.268 M | 25.453 M | 5.468 M | 30.920 M | 25.909 M | |
| -161.35% | -34.85% | 496.37% | -78.52% | 465.47% | -16.21% | |||
| Income tax | 29.000 K | -328.000 K | 388.000 K | 2.122 M | 408.000 K | 2.733 M | -364.986 M | |
| Net income basic | -10.707 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | ||||||||
| Net income | -10.707 M | 6.879 M | 3.880 M | 23.331 M | 5.060 M | 28.187 M | 390.895 M | |
| 164.25% | -43.60% | 501.31% | -78.31% | 457.06% | 1,286.79% |